These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38874512)

  • 1. Identification of VEGFs-related gene signature for predicting microangiogenesis and hepatocellular carcinoma prognosis.
    Jiang S; Zhu G; Tan Y; Zhou T; Zheng S; Wang F; Lei W; Liu X; Du J; Tian M
    Aging (Albany NY); 2024 Jun; 16(12):10321-10347. PubMed ID: 38874512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
    Yang S; Yang C; Yu F; Ding W; Hu Y; Cheng F; Zhang F; Guan B; Wang X; Lu L; Rao J
    Cell Death Dis; 2018 Oct; 9(11):1105. PubMed ID: 30377291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma.
    Wang W; Wang L; Xie X; Yan Y; Li Y; Lu Q
    BMC Cancer; 2021 Jan; 21(1):6. PubMed ID: 33402113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.
    Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X
    Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
    Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF.
    Cheng J; Chen Y; Zhao P; Liu X; Dong J; Li J; Huang C; Wu R; Lv Y
    Oncotarget; 2016 May; 7(21):30702-11. PubMed ID: 27120793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification.
    Ouyang G; Li Q; Wei Y; Dai W; Deng H; Liu Y; Li J; Li M; Luo S; Li S; Liang Y; Pan G; Yang J; Gan T
    Front Immunol; 2024; 15():1323199. PubMed ID: 38742112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
    Zhen Z; Shen Z; Hu Y; Sun P
    Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma.
    Zhu J; Huang S; Wu G; Huang C; Li X; Chen Z; Zhao L; Zhao Y
    Dig Dis Sci; 2015 Oct; 60(10):3019-31. PubMed ID: 26048020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF Family Gene Expression as Prognostic Biomarkers for Alzheimer's Disease and Primary Liver Cancer.
    Xu K; Wu CL; Wang ZX; Wang HJ; Yin FJ; Li WD; Liu CC; Fan HN
    Comput Math Methods Med; 2021; 2021():3422393. PubMed ID: 34845413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA PAARH promotes hepatocellular carcinoma progression and angiogenesis via upregulating HOTTIP and activating HIF-1α/VEGF signaling.
    Wei H; Xu Z; Chen L; Wei Q; Huang Z; Liu G; Li W; Wang J; Tang Q; Pu J
    Cell Death Dis; 2022 Feb; 13(2):102. PubMed ID: 35110549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of interleukin-32α promotes invasion by modulating VEGF in hepatocellular carcinoma.
    Zhao WB; Wang QL; Xu YT; Xu SF; Qiu Y; Zhu F
    Oncol Rep; 2018 Mar; 39(3):1155-1162. PubMed ID: 29286122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of a new gene signature predicting prognosis of hepatocellular carcinoma patients by network analysis of stemness indices.
    Cai JL; Zhu GQ; Du JX; Wang B; Wan JL; Xiao K; Dai Z
    Expert Rev Gastroenterol Hepatol; 2021 Jun; 15(6):699-709. PubMed ID: 33131341
    [No Abstract]   [Full Text] [Related]  

  • 16. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.
    Ye ZL; Huang Y; Li LF; Zhu HL; Gao HX; Liu H; Lv SQ; Xu ZH; Zheng LN; Liu T; Zhang JL; Jin HJ; Qian QJ
    Acta Pharmacol Sin; 2015 Oct; 36(10):1237-45. PubMed ID: 25937637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma.
    Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ
    Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma.
    Huo J; Wu L; Zang Y; Dong H; Liu X; He F; Zhang X
    BMC Cancer; 2021 Jan; 21(1):31. PubMed ID: 33413205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of renin-angiotensin system genes with the progression of hepatocellular carcinoma.
    Ye G; Qin Y; Lu X; Xu X; Xu S; Wu C; Wang X; Wang S; Pan D
    Biochem Biophys Res Commun; 2015 Mar; 459(1):18-23. PubMed ID: 25701390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of a hub gene prognostic index for hepatocellular carcinoma.
    Shi Q; Meng Z; Tian XX; Wang YF; Wang WH
    Future Oncol; 2021 Jun; 17(17):2193-2208. PubMed ID: 33620260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.